 |
 Versión impresora
Propiedad intelectual y salud pública
Patentes, innovación y acceso
Comentaristas académicos, diversos informes oficiales y algunos usuarios del sistema de patentes, incluidos los que participan en la investigación de vacunas y tratamientos para enfermedades «desatendidas», se preguntan hasta qué punto son eficaces o pertinentes los incentivos que ofrece el sistema de patentes, y si acaso no habría que mejorarlos para responder más eficazmente a algunas enfermedades que afectan especialmente a los países en desarrollo. Otro de los temas planteados es el de la influencia de la propiedad intelectual en el acceso a los medicamentos.
Documentos
-
Más información - en inglés
-
Testimony of the Biotechnology Industry Organization on Competition and Intellectual Property Law and Policy in the Knowledge E-Based Economy Before the Federal Trade Commission and the Department of Justice | Competition Policy Center and the Berkeley Center for Law and Technology | University of California at Berkeley | 26 February 2002
-
Patents and Innovation: Trends and Policy Challenges | OECD | Paris, 2004
-
How Do Patents And Economic Policies Affect Access To Essential Medicines In Developing Countries? | By Amir Attaran | Health Affairs, Vol 23, Issue 3, 155-166 | May/ June 2004
-
A Patent System for the 21st Century | By S. A. Merill, R. C. Levin, M. B. Myers | Committee on Intellectual Property Rights in the Knowledge-Based Economy, Board on Science, Technology and Economic Policy | National Research Council | 2004
-
To Promote Innovation: The Proper Balance of Competition and Patent Law and Policy | A Report by the Federal Trade Commission | October 2003
-
Keeping science open: the effects of intellectual property policy on the conduct of science | The Royal Society | 2003
-
Global Welfare in Pharmaceutical Patenting | F. M. Scherer | December 2003
-
Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India | By S. Chaudhuri, P. Goldberg, P. Jia, mimeo | December 2003
-
Integrating Intellectual Property Rights and Development Policy | UK Commission on Intellectual Property Rights | 2002
-
The Ethics of Patenting DNA: A Discussion Paper | Nuffield Council on Bioethics | 2002
-
Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment In Africa | By A. Attaran & L. Gillespie-White 2001 JAMA, vol. 286:15
-
Post- TRIPS options for access to patented medicines in developing Countries | F.M.Scherer & Jayashree Watal | CMH Working Paper 4:1 | January 2001
-
How Stronger Patent Protection in India Might Affect the Behavior of Transnational Pharmaceutical Industries | C. Fink | World Bank Working Paper No 2352 | 2000
-
Strengthening Protection of Intellectual Property in Developing Countries: A Survey of the Literature | Wolfgang E. Siebeck, editor, with Robert E. Evenson, William Lesser, and Carlos A. Primo Braga | 1990
-
A Better Way to Spur Medical Research and Development | By Rachel Glennerster and Michael Kremer
-
IPR, Innovation, Human Rights and Access to Drugs [pdf 801kb]
Otros documentos relacionados
-
- Taller de la OMS sobre derechos de propiedad intelectual y vacunas en los países en desarrollo, 19 y 20 de abril de 2004, Ginebra, Suiza (en inglés)
-
Volver a Propiedad intelectual y salud pública
|
